Program and Abstracts from the Canadian Digestive Diseases Week 2016

Figure 32

Markov model simulating the progression of a cohort of patients with moderate to severe ulcerative colitis, who are corticosteroid-dependent or refractory to thiopurines, in situations where adalimumab is readily available compared to situations when it is unavailable.